ABL1 and chronic graft versus host disease: According to the map, depending on the presence or absence of chronic GVHD and the definite levels ​​of the BCR::ABL1, the patient can be assigned to a group of high (the relapse risk is over 20%) or low (the relapse risk is less 20%) risk of relapse.